Wyeth Korea to launch pneumococcal conjugated vaccine Prevenar

Published: 2003-11-17 06:57:00
Updated: 2003-11-17 06:57:00
Wyeth Korea announced on November 12 that Prevenar received marketing authorization from the Korea Food and Drug Administration.

The vaccine is the first and only pneumococcal conjugated vaccine indicated for infants and young children younger than two years (an age group exposed to a higher ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.